Immunization Delivery in Obstetrics and Gynecology Settings

• Change in the percent of women vaccinated with one or more Tdap vaccines (among eligible patients) in intervention settings compared to control settings. [ Time Frame: 1 year (administrative data) & 2 months (survey data) prior to intervention & two years after intervention at 1 year intervals (administrative and survey data) ] [ Designated as safety issue: No ]
  The percent of eligible patients presenting for care who receive Tdap vaccine will be assessed one year prior to the intervention and two years after the intervention at one year intervals. This assessment will occur in both intervention and control settings using two data sources 1) administrative data and 2) patient self-report of vaccine history.
• Change in the percent of women vaccinated with influenza vaccine (among eligible patients) in intervention settings compared to control settings. [ Time Frame: 1 year (administrative data) & 2 months (survey data) prior to intervention & two years after intervention at 1 year intervals (administrative and survey data) ] [ Designated as safety issue: No ]
  The percent of eligible patients presenting for care who receive influenza vaccine will be assessed one year prior to the intervention and two years after the intervention at one year intervals. This will be assessed in both intervention and control settings using two data sources 1) administrative data and 2) patient self-report of vaccine history.
• Change in the percent of women who have initiated the HPV vaccine series (among eligible patients) in intervention settings compared to control settings. [ Time Frame: 1 year (administrative data) & 2 months (survey data) prior to intervention & two years after intervention at 1 year intervals (administrative and survey data) ] [ Designated as safety issue: No ]
  The percent of eligible patients presenting for care who have received one or more HPV vaccines will be assessed one year prior to the intervention and two years after the intervention at one year intervals. This number will be assess in both intervention and control settings using two data sources 1) administrative data and 2) patient self-report of vaccine history.
• Change in the percent of women who have received one or more needed vaccines (eligible patients who receive HPV, influenza, and/or Tdap vaccines) in intervention settings compared to control settings. [ Time Frame: 1 year (administrative data) & 2 months (survey data) prior to intervention & two years after intervention at 1 year intervals (administrative and survey data) ] [ Designated as safety issue: No ]
  The percent of eligible patients presenting for care who have received one or more needed vaccines (HPV, Tdap, and/or influenza vaccines) will be assessed one year prior to the intervention and two years after the intervention at one year intervals. This number will be assess in both intervention and control settings using two data sources 1) administrative data and 2) patient self-report of vaccine history.

• Change in the percent of women vaccinated with one or more Tdap vaccines (among eligible patients) in intervention settings compared to control settings. [ Time Frame: 1 year (administrative data) & 3 months (survey data) prior to intervention & two years after intervention at 1 year intervals (administrative and survey data) ] [ Designated as safety issue: No ]
  The number and percent of eligible patients presenting for care who receive Tdap vaccine will be assessed one year prior to the intervention and two years after the intervention at one year intervals. This assessment will occur in both intervention and control settings using two data sources 1) administrative data and 2) patient self-report of vaccine history.
• Change in the percent of women vaccinated with influenza vaccine (among eligible patients) in intervention settings compared to control settings. [ Time Frame: 1 year (administrative data) & 3 months (survey data) prior to intervention & two years after intervention at 1 year intervals (administrative and survey data) ] [ Designated as safety issue: No ]
  The number and percent of eligible patients presenting for care who receive influenza vaccine will be assessed one year prior to the intervention and two years after the intervention at one year intervals. This will be assessed in both intervention and control settings using two data sources 1) administrative data and 2) patient self-report of vaccine history.
• Change in the number women who have initiated the HPV vaccine series (among eligible patients) in intervention settings compared to control settings. [ Time Frame: 1 year (administrative data) & 3 months (survey data) prior to intervention & two years after intervention at 1 year intervals (administrative and survey data) ] [ Designated as safety issue: No ]
  The number and percent of eligible patients presenting for care who have received one or more HPV vaccines will be assessed one year prior to the intervention and two years after the intervention at one year intervals. This number will be assess in both intervention and control settings using two data sources 1) administrative data and 2) patient self-report of vaccine history.

• Change in the percent of women who have completed the HPV vaccine series (among eligible patients) in intervention settings compared to control settings. [ Time Frame: 1 year (administrative data) & 2 months (survey data) prior to intervention & two years after intervention at 1 year intervals (administrative and survey data) ] [ Designated as safety issue: No ]
  The percent of eligible patients presenting for care who have completed the HPV vaccine series will be assessed one year prior to the intervention and two years after the intervention at one year intervals. This number will be assess for both intervention and control settings using two data sources 1) administrative data and 2) patient self-report of vaccine history.
• Change in the percent of women who report Tdap vaccine uptake among individuals in frequent contact with their infant in intervention offices compared to control offices [ Time Frame: Feb/March 2013 & Feb/March 2014 ] [ Designated as safety issue: No ]
  The percent of patients who report one or more individuals who are/will be in frequent contact with their infant having received Tdap vaccine will be assessed during Feb/March 2013 and Feb/March 2014. These data will be collected in patients of both intervention and control settings via on-line survey and be administered to patients who volunteer to take the survey.
• Change in the percent of women who report influenza vaccine uptake among individuals in frequent contact with their infant in intervention offices. compared to control offices [ Time Frame: Feb/March 2013 & Feb/March 2014 ] [ Designated as safety issue: No ]
  The percent of patients who report one or more individuals who are/will be in frequent contact with their infant having received influenza vaccine will be assessed during Feb/March 2013 and Feb/March 2014. These data will be collected in patients of both intervention and control settings via on-line survey and be administered to patients who volunteer to take the survey.

The purpose of this study is to determine if a mulitmodal immunization program carried out in obstetrics and gynecology (ob/gyn) practices would be more effective in improving ob/gyn patients' immunization rates, specifically for Tdap, HPV, and influenza vaccines, than the usual care provided to patients in ob/gyn practices.

• Experimental: Intervention Practices
  Intervention offices will adopt a multimodal vaccine program to increase their patients' vaccine rates.
  Intervention: Behavioral: Multimodal Vaccine Program
• No Intervention: Control Practices
  Control offices will offer usual health care related to immunizations throughout the duration of the study.

Inclusion Criteria:

1. 15 years of age or older when presenting for care
2. Patients who present for care one year prior to the start of the intervention and up to two years after the start of the intervention

Exclusion Criteria:

1. less than 15 years of age when presenting for care
2. patient is not eligible for any immunizations